![Company](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_CMN_Companies_to_Follow_2023_01_17_81d7a58868_1c503a0f51.png)
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Intima Bioscience
Main focus: Next generation cell therapies for solid tumours
Company stage: Clinical
Diseases: Multiple solid tumours
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: New York, USA
Website: https://www.intimabioscience.com/
![](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_intimabio_1d9fb3c9b7_0b8638b4cd.jpg)
Intima Bioscience is a clinical-stage gene and cell therapy company focused on developing cures for solid cancers. The company develops tumour-infiltrating lymphocytes (TILs) in which the novel cytokine checkpoint CISH is disrupted using CRISPR. The company is currently testing its lead programme in multiple solid tumours in a Phase 1/2 clinical trial.